Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118649615 | 11864961 | 5 | F | 201508 | 20160810 | 20151223 | 20160817 | PER | US-PFIZER INC-2015440840 | PFIZER | 63.00 | YR | F | Y | 55.34000 | KG | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118649615 | 11864961 | 1 | PS | LYRICA | PREGABALIN | 1 | 100 MG, 3X/DAY | Y | L85722 | 21446 | 100 | MG | CAPSULE, HARD | TID | |||||
| 118649615 | 11864961 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, 3X/DAY | Y | 21446 | 200 | MG | CAPSULE, HARD | TID | |||||
| 118649615 | 11864961 | 3 | SS | LYRICA | PREGABALIN | 1 | 600 MG, 3X/DAY | Y | 21446 | 600 | MG | CAPSULE, HARD | TID | ||||||
| 118649615 | 11864961 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, 3X/DAY | Y | M84693 | 21446 | 200 | MG | CAPSULE, HARD | TID | ||||
| 118649615 | 11864961 | 5 | C | OXYCODONE | OXYCODONE | 1 | 1 DF, 4X/DAY | 0 | 1 | DF | QID | ||||||||
| 118649615 | 11864961 | 6 | C | ATENOLOL. | ATENOLOL | 1 | 1 DF, UNK | 0 | 1 | DF | TABLET | ||||||||
| 118649615 | 11864961 | 7 | C | CITALOPRAM HYDROBROMIDE. | CITALOPRAM HYDROBROMIDE | 1 | 20 MG, 1X/DAY (40MG TABLET 0.5 TABLETONCE A DAY) | 0 | 20 | MG | TABLET | QD | |||||||
| 118649615 | 11864961 | 8 | C | HYDROXYZINE PAMOATE. | HYDROXYZINE PAMOATE | 1 | 50 MG, AS NEEDED (1 CAPSULE AS NEEDED EVERY 6HRS) | 0 | 50 | MG | CAPSULE | ||||||||
| 118649615 | 11864961 | 9 | C | LORAZEPAM. | LORAZEPAM | 1 | 1 MG, AS NEEDED (1MG TABLET, 1 TABLET AS NEEDED TWICE A DAY) | 0 | 1 | MG | TABLET | ||||||||
| 118649615 | 11864961 | 10 | C | ATIVAN | LORAZEPAM | 1 | 1 MG, AS NEEDED(1MG TABLET, 1 TABLET AS NEEDED TWICE A DAY) | 0 | 1 | MG | TABLET | ||||||||
| 118649615 | 11864961 | 11 | C | PRIMATENE | EPHEDRINE HYDROCHLORIDEGUAIFENESIN | 1 | 1 DF, AS NEEDED (EVERY 4 HRS) | 0 | 1 | DF | TABLET | ||||||||
| 118649615 | 11864961 | 12 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | (OXYCODONE HYDROCHLORIDE:10MG /PARACETAMOL: 325MG) TABLET AS NEEDED EVERY 6 HRS | 0 | 1 | DF | TABLET | ||||||||
| 118649615 | 11864961 | 13 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | UNK, 4X/DAY (OXYCODONE HYDROCHLORIDE: 10MG, PARACETAMOL: 325MG) | 0 | TABLET | QID | ||||||||
| 118649615 | 11864961 | 14 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | 0.25 MG, 1X/DAY ( TABLET 1 TO 3 HOURS BEFORE BEDTIME ONCE A DAY) | 0 | .25 | MG | TABLET | QD | |||||||
| 118649615 | 11864961 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | 400 MG, 3X/DAY | 0 | 400 | MG | CAPSULE | TID | |||||||
| 118649615 | 11864961 | 16 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 4 MG, 2X/DAY | 0 | 4 | MG | TABLET | BID | |||||||
| 118649615 | 11864961 | 17 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG, ONCE A DAY | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118649615 | 11864961 | 1 | Neuropathy peripheral |
| 118649615 | 11864961 | 2 | Diabetic neuropathy |
| 118649615 | 11864961 | 5 | Neuropathy peripheral |
| 118649615 | 11864961 | 11 | Asthma |
| 118649615 | 11864961 | 12 | Neuropathy peripheral |
| 118649615 | 11864961 | 17 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118649615 | 11864961 | Anxiety | |
| 118649615 | 11864961 | Balance disorder | |
| 118649615 | 11864961 | Drug dose omission | |
| 118649615 | 11864961 | Drug effect incomplete | |
| 118649615 | 11864961 | Dysgraphia | |
| 118649615 | 11864961 | Intentional product misuse | |
| 118649615 | 11864961 | Intentional product use issue | |
| 118649615 | 11864961 | Myoclonus | |
| 118649615 | 11864961 | Nausea | |
| 118649615 | 11864961 | Prescribed overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118649615 | 11864961 | 1 | 201508 | 0 | ||
| 118649615 | 11864961 | 2 | 201508 | 20151014 | 0 | |
| 118649615 | 11864961 | 3 | 20151208 | 0 | ||
| 118649615 | 11864961 | 5 | 201501 | 0 |